--- title: "Azurity Pharmaceuticals, Inc. Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Azurity Pharmaceuticals, Inc. recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/azurity-pharmaceuticals-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Azurity Pharmaceuticals, Inc. recall records **0** reported ongoing 4 records in this archive. Latest source date Jan 25, 2024. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Jan 25, 2024 FDA company announcement ### [Zendedi: dextroamphetamine sulfate tablets, 30 mg](https://isitonrecall.com/recall/fdapress-9e3b75f480838189-zendedi-dextroamphetamine-sulfate-tablets-30-mg/) Mislabeled package Not supplied Reported terminated Distribution: Not supplied [Official source for Zendedi: dextroamphetamine sulfate tablets, 30 mg](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate) Jan 4, 2024 FDA drug enforcement ### [Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03](https://isitonrecall.com/recall/fda-drug-d-0323-2024-zenzedi-dextroamphetamine-sulfate-cii-tablets-usp-30-mg-30-count-bottle-rx-only-mfd-for-arbor-pharma/) Labeling: Label Mix-up Class I Reported terminated Distribution: USA nationwide [Official source for Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0323-2024%22) Dec 8, 2023 FDA drug enforcement ### [Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1](https://isitonrecall.com/recall/fda-drug-d-0213-2024-eprontia-topiramate-oral-solution-25-mg-ml-473-ml-bottle-rx-only-manufactured-for-azurity-pharmaceut/) Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months. Class III Reported terminated Distribution: USA nationwide. [Official source for Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0213-2024%22) Feb 15, 2023 FDA drug enforcement ### [Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, M...](https://isitonrecall.com/recall/fda-drug-d-0489-2023-testosterone-cypionate-injection-usp-ciii-200-mg-ml-packaged-in-a-10-ml-multiple-dose-vials-ndc-5253/) cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. Class II Reported terminated Distribution: US Nationwide [Official source for Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0489-2023%22) ## Reasons in these listed records - Mislabeled package - Labeling: Label Mix-up - Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months. - cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. These examples come from this result page and are not a ranking of every recall reason. ## Checking Azurity Pharmaceuticals, Inc. ### Is there a recall on azurity pharmaceuticals, inc. right now? This archive contains 4 records, including 0 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Azurity Pharmaceuticals, Inc.](https://isitonrecall.com/check/?q=Azurity%20Pharmaceuticals%2C%20Inc.) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)